1. Home/
  2. Compounds/
  3. navitoclax:birinapant (1:1 mol/mol)

navitoclax:birinapant (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:birinapant (1:1 mol/mol)
PharmacoGx navitoclax:birinapant (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:birinapant (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF71 CTRPv2 pan-cancer AAC 0.22 7e-08
mRNA CNTN4 CTRPv2 pan-cancer AAC 0.19 8e-08
mRNA DAP3 CTRPv2 pan-cancer AAC -0.2 8e-08
mRNA ZNF461 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA NCKAP1L CTRPv2 pan-cancer AAC 0.28 1e-07
mRNA NUMA1 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA NIT1 CTRPv2 pan-cancer AAC -0.18 2e-07
mRNA ZNF610 CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA RSBN1 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA ZNF491 CTRPv2 pan-cancer AAC 0.19 3e-07
Download CSV